GlassScriptPhysician profile
Kimberly Colangelo
NPI 1659902831
$3,814.83
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,066 · 2023: $1,722 · 2024: $26.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686 · Education: $62.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,685.64 |
| Education | $62.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $843.35 | 2022-2023 | Austedo, Austedo Xr |
| Abbvie INC. | $709.55 | 2022-2024 | |
| Alkermes, INC. | $340.39 | 2022-2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $334.81 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $280.55 | 2022-2023 | Rexulti, Abilify Maintena, Nuedexta |
| Lundbeck LLC | $245.97 | 2022-2023 | Brintellix, Abilify Maintena |
| Neurocrine Biosciences, INC. | $224.96 | 2022-2023 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $183.73 | 2022-2023 | Trintellix |
| Indivior INC. | $168.12 | 2022-2023 | Perseris |
| Almatica Pharma LLC | $139.01 | 2022 | |
| Bausch Health US, LLC | $85.77 | 2022-2023 | Aplenzin |
| Janssen Pharmaceuticals, INC | $69.41 | 2022-2023 | Invega Sustenna |
| Sunovion Pharmaceuticals INC. | $68.19 | 2022 | |
| Noven Therapeutics, LLC | $54.56 | 2022 | |
| Neuronetics, INC. | $45.58 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $20.88 | 2023 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Colangelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.